Stefan Galluppi insider trades
Open-market stock purchases and sales by Stefan Galluppi, Chief Innovation Officer at LifeMD, Inc, from SEC Form 4 filings since Apr 25, 2019.
Track record: 80% of 5 scored buys are up 5% or more since purchase, averaging +24%.
Recent trades
No open-market trades in the last 12 months.